X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (35) 35
humans (31) 31
male (21) 21
hematology (19) 19
middle aged (17) 17
female (16) 16
aged (14) 14
adult (13) 13
medicine, general & internal (7) 7
oncology (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
expression (6) 6
multiple myeloma (6) 6
japan (5) 5
mutation (5) 5
phenotype (5) 5
aged, 80 and over (4) 4
animals (4) 4
fatal outcome (4) 4
mice (4) 4
peripheral t-cell lymphoma (4) 4
retrospective studies (4) 4
rituximab (4) 4
survival (4) 4
treatment outcome (4) 4
abridged index medicus (3) 3
antigens, cd - analysis (3) 3
apoptosis (3) 3
bortezomib (3) 3
care and treatment (3) 3
case report (3) 3
cd56 (3) 3
death (3) 3
dexamethasone (3) 3
dna-binding proteins - genetics (3) 3
dose-response relationship, drug (3) 3
drug therapy (3) 3
epstein-barr-virus (3) 3
gene (3) 3
growth (3) 3
induction (3) 3
killer cells, natural - pathology (3) 3
leukemia (3) 3
lymphomas (3) 3
medical research (3) 3
multiple myeloma - drug therapy (3) 3
patient outcomes (3) 3
patients (3) 3
peripheral neuropathy (3) 3
platelet count (3) 3
remission induction (3) 3
transplantation (3) 3
aggressive neoplasm (2) 2
antigens, cd34 - analysis (2) 2
antigens, differentiation, myelomonocytic - analysis (2) 2
antineoplastic agents (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
apoptosis - drug effects (2) 2
autologous stem cell transplantation (2) 2
band 3 (2) 2
biology (2) 2
cd56 antigen - analysis (2) 2
cell count (2) 2
cell differentiation - physiology (2) 2
chemotherapy (2) 2
clinicopathological features (2) 2
cloning (2) 2
colony-stimulating factor (2) 2
cyclophosphamide (2) 2
cytotoxic t-cell lymphoma (2) 2
dexamethasone - administration & dosage (2) 2
drug dosages (2) 2
drug therapy, combination (2) 2
erythroid-specific dna-binding factors (2) 2
erythropoiesis (2) 2
erythropoietin (2) 2
gene expression (2) 2
gene mutations (2) 2
genetic aspects (2) 2
hematopoiesis - physiology (2) 2
immunophenotyping (2) 2
induced thrombocytopenia (2) 2
inhibitor (2) 2
karyotyping (2) 2
leukemia, myeloid, acute - pathology (2) 2
leukemoid reaction (2) 2
lymphoma, b-cell - pathology (2) 2
lymphoma, t-cell - diagnosis (2) 2
lymphoma, t-cell - immunology (2) 2
lymphoma, t-cell, peripheral - diagnosis (2) 2
lymphoma, t-cell, peripheral - pathology (2) 2
medical prognosis (2) 2
medicine (2) 2
medicine & public health (2) 2
medicine, research & experimental (2) 2
megakaryocytes (2) 2
megakaryocytes - cytology (2) 2
megakaryocytes - pathology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Genetics, ISSN 1061-4036, 2014, Volume 46, Issue 2, pp. 171 - 175
Journal Article
International journal of clinical oncology, ISSN 1341-9625, 07/2019
The prevention of invasive fungal infections is important in patients with acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS) receiving cytoreductive... 
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2016, Volume 374, Issue 17, pp. 1621 - 1634
The addition of the oral proteasome inhibitor ixazomib to a regimen of lenalidomide plus dexamethasone led to a significant prolongation of progression-free... 
SUPERIORITY | MEDICINE, GENERAL & INTERNAL | CARFILZOMIB | RANDOMIZED PHASE-3 | THERAPY | PROTEASOME INHIBITOR MLN9708 | QUALITY-OF-LIFE | BORTEZOMIB | THALIDOMIDE | ANTITUMOR-ACTIVITY | TRANSPLANTATION | Glycine - analogs & derivatives | Glycine - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Boron Compounds - administration & dosage | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Exanthema - chemically induced | Aged, 80 and over | Adult | Glycine - administration & dosage | Dexamethasone - administration & dosage | Double-Blind Method | Administration, Oral | Kaplan-Meier Estimate | Proportional Hazards Models | Thrombocytopenia - chemically induced | Thalidomide - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quality of Life | Boron Compounds - adverse effects | Aged | Care and treatment | Dosage and administration | Dexamethasone | Multiple myeloma | Thrombocytopenia | Inhibitor drugs | Risk groups | Drug therapy | Peripheral neuropathy | Survival | Patients | Drug dosages | Proteasome inhibitors | Quality of life | Index Medicus | Abridged Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2014, Volume 9, Issue 10, pp. e109714 - e109714
Journal Article
Gan to kagaku ryoho. Cancer & chemotherapy, ISSN 0385-0684, 05/2019, Volume 46, Issue 5, p. 913
T-cell prolymphocytic leukemia(T-PLL)is a highly aggressive hematopoietic malignancy with poor prognosis and is extremely rare in Japan. Since T-PLL cells... 
Antibodies, Monoclonal, Humanized | Humans | Japan | Leukemia, Prolymphocytic, T-Cell - drug therapy | Middle Aged | Antineoplastic Agents | Female | Alemtuzumab - therapeutic use
Journal Article
International Journal of Hematology, ISSN 0925-5710, 5/2011, Volume 93, Issue 5, pp. 618 - 623
The correlation between imatinib (IM) trough plasma concentration (Cmin) and clinical response was assessed in patients with chronic-phase chronic myeloid... 
Imatinib | Medicine & Public Health | Hematology | Plasma concentration | Oncology | Chronic myeloid leukemia | Molecular response | CHRONIC-PHASE | BCR-ABL | RISK | CYTARABINE | MESYLATE | TRIAL | INTERFERON | THERAPY | PHARMACOKINETICS | RESISTANCE | HEMATOLOGY | Piperazines - administration & dosage | Humans | Leukemia, Myeloid, Chronic-Phase - pathology | Middle Aged | Male | Dose-Response Relationship, Drug | Drug Dosage Calculations | Protein-Tyrosine Kinases - genetics | Fusion Proteins, bcr-abl - blood | Female | Remission Induction - methods | Retrospective Studies | Cytogenetic Analysis | Piperazines - pharmacokinetics | Protein Kinase Inhibitors - pharmacokinetics | Cross-Sectional Studies | Pyrimidines - administration & dosage | Japan | Leukemia, Myeloid, Chronic-Phase - blood | Leukemia, Myeloid, Chronic-Phase - drug therapy | In Situ Hybridization, Fluorescence | Treatment Outcome | Imatinib Mesylate | Protein-Tyrosine Kinases - blood | Protein Kinase Inhibitors - administration & dosage | Fusion Proteins, bcr-abl - genetics | Fusion Proteins, bcr-abl - antagonists & inhibitors | Pyrimidines - pharmacokinetics | Aged | Benzamides | Protein-Tyrosine Kinases - antagonists & inhibitors | Antimitotic agents | Care and treatment | Myelocytic leukemia | Analysis | Nonlymphoid leukemia | Antineoplastic agents | Standards | Medical research | Medicine, Experimental | Index Medicus
Journal Article
Journal of Clinical and Experimental Hematopathology, ISSN 1346-4280, 2015, Volume 55, Issue 2, pp. 61 - 69
Angioimmunoblastic T-cell lymphoma (AITL) is considered to originate from follicular helper T (TFH) cells. Currently, neoplastic cells in AITL are considered... 
angioimmunoblastic T-cell lymphoma | CXCR5 | follicular helper T cells | CXCL13 | follicular dendritic cells
Journal Article
[Rinsho ketsueki] The Japanese journal of clinical hematology, ISSN 0485-1439, 2018, Volume 59, Issue 11, p. 2399
Based on the outcomes of the TOURMALINE-MM1 trial-a global, randomized, double-blind, placebo-controlled phase III clinical study-the use of an oral proteasome... 
Journal Article
Journal Article
Journal Article
Molecular and clinical oncology, ISSN 2049-9450, 06/2016, Volume 4, Issue 6, p. 965
Maintenance therapy with lenalidomide (LEN) for patients with multiple myeloma (MM) following autologous peripheral blood stem cell transplantation... 
Journal Article
Acta Haematologica, ISSN 0001-5792, 06/2015, Volume 134, Issue 1, pp. 25 - 31
Journal Article
Cases Journal, ISSN 1757-1626, 05/2009, Volume 2, Issue 5, p. 6646
Primary mantle cell lymphoma of the esophagus is quite rare, and we report here a case of a submucosal polypoid tumor of the esophagus that was pathologically... 
Case studies | Care and treatment | Diagnosis | Patient outcomes | Esophageal cancer
Journal Article
Cases Journal, ISSN 1757-1626, 05/2009, Volume 2, Issue 1, pp. 6646 - 6646
INTRODUCTION: Primary mantle cell lymphoma of the esophagus is quite rare, and we report here a case of a submucosal polypoid tumor of the esophagus that was... 
Journal Article
Journal Article